1. HBW Insight
  2. >>ESG
  3. >>Diversity & Inclusion

Diversity Enrichment: US FDA Guidance Suggests Sponsors May Need To Overenroll Key Groups

 
• By Sarah Karlin-Smith

New draft guidance on clinical trial diversity action plans pushes for disproportionately high enrollment of traditionally underrepresented groups, while also asking companies to tailor global programs to US populations and consider diversity aspects that Congress did not outline. 

overflowing coffee cup with coffee spilled on table
While greater than proportional enrollment may be necessary, the FDA will not conduct statistical testing on population subgroups. • Source: Shutterstock

Drug and medical device sponsors may need to overenroll key patient populations under the US Food and Drug Administration’s new diversity action plan guidance, a move that could make the revamped clinical trial diversity push more challenging than anticipated.

Read the full article – start your free trial today!

Join thousands of industry professionals who rely on HBW Insight for daily insights

  • Start your 7-day free trial
  • Explore trusted news, analysis, and insights
  • Access comprehensive global coverage
  • Enjoy instant access – no credit card required
Start Free Trial

Already a subscriber?

More from Diversity & Inclusion

Beauty Deserts, People With Disabilities, Hormonal Health: FIT Grads On Inclusivity Gaps

 
• By Ryan Nelson

The Fashion Institute of Technology’s “Beauty Think Tank” provides findings from six months of consumer research to “help guide organizations through the evolving landscape of beauty and accessibility.”

Diversity Action Plans Should Be Brief And Waiver Requests Filed Early, US FDA Says

 
• By Sue Sutter

In what could amount to a de facto enforcement mechanism, the new draft guidance also “strongly encourages” sponsors to share details about their diversity action plan and enrollment goals with the public.

Diversity Enrichment: US FDA Guidance Suggests Sponsors May Need To Overenroll Key Groups

 
• By Sarah Karlin-Smith

New draft guidance on clinical trial diversity action plans pushes for disproportionately high enrollment of traditionally underrepresented groups, while also asking companies to tailor global programs to US populations and consider diversity aspects that Congress did not outline. 

Hair-Care News: Connecticut Mandates Inclusive Hair Education; Fenty Hair; Virtue Labs, More

 
• By Ryan Nelson

A Connecticut bill signed into law on 28 May requires barbers, hairdressers and cosmeticians to be educated and trained on textured hair. Niles + Chaz launches with four products designed for children with “mixed-textured hair,” while Rion Aesthetics says (plated) Hair Serum is the first and only product of its kind with platelet-derived exosomes. More hair-care news.

More from ESG

EU Urban Wastewater Directive ‘Highly Disproportionate,’ Says AESGP

 
• By David Ridley

Pharmaceutical industry associations are united in their view that the revised EU Urban Wastewater Treatment Directive discriminates against medicines and cosmetics producers.

Kenvue’s Carlton Lawson: Reverse-Switching Antimicrobials ‘Not The Answer’ To AMR

 
• By David Ridley

Kenvue's EMEA and LATAM head Carlton Lawson acknowledges the urgency of environmental issues like antimicrobial resistance and wastewater pollution in this interview with HBW Insight, but calls for a more balanced approach on the part of European regulators.

Two-Thirds Of UK Consumers Turned Off By Eco Price Premium

 
• By David Ridley

While the majority of British consumers don't want to pay more for eco-conscious products like foods and cosmetics, one in five would pay more for sustainable premium and luxury products and fast-moving consumer goods, reports Clear Channel.